THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 34 filers reported holding THERAVANCE INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $37,000 | -99.6% | 37,000 | -99.6% | 0.00% | -100.0% |
| Q3 2019 | $9,309,000 | -44.6% | 9,910,000 | -38.0% | 0.05% | -45.2% |
| Q2 2019 | $16,789,000 | +2.3% | 15,972,000 | -1.0% | 0.09% | -8.8% |
| Q1 2019 | $16,409,000 | -5.6% | 16,134,000 | -0.1% | 0.10% | -11.3% |
| Q4 2018 | $17,383,000 | +5.5% | 16,155,000 | -0.2% | 0.12% | +26.4% |
| Q3 2018 | $16,483,000 | +4.6% | 16,192,000 | -0.0% | 0.09% | -5.2% |
| Q2 2018 | $15,762,000 | -8.6% | 16,199,000 | +0.0% | 0.10% | -14.3% |
| Q1 2018 | $17,238,000 | +6.1% | 16,191,000 | -1.3% | 0.11% | +34.9% |
| Q4 2017 | $16,250,000 | +0.9% | 16,402,000 | -0.7% | 0.08% | -33.6% |
| Q3 2017 | $16,111,000 | +175.6% | 16,513,000 | +312.8% | 0.12% | +237.8% |
| Q4 2013 | $5,845,000 | -10.6% | 4,000,000 | 0.0% | 0.04% | -9.8% |
| Q3 2013 | $6,537,000 | +5.6% | 4,000,000 | 0.0% | 0.04% | +2.5% |
| Q2 2013 | $6,188,000 | – | 4,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 40,888,000 | $41,182,000 | 8.34% |
| Castle Creek Arbitrage, LLC | 3,583,000 | $3,611,000 | 0.83% |
| LINDEN ADVISORS LP | 68,022,000 | $68,478,000 | 0.81% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,565,000 | $35,953,000 | 0.70% |
| CSS LLC/IL | 6,234,000 | $6,267,000 | 0.35% |
| AQR Arbitrage LLC | 18,768,000 | $18,903,000 | 0.32% |
| SSI INVESTMENT MANAGEMENT LLC | 3,000,000 | $3,006,000 | 0.20% |
| Wellesley Asset Management | 927 | $934,000 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 19,500,000 | $19,639,000 | 0.03% |
| Daiwa Securities Group Inc. | 2,500,000 | $2,511,000 | 0.02% |